drugset / Trial / NCT00425932

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

NCT00425932 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to further investigate rituximab in the treatment of rheumatoid arthritis and to evaluate magnetic resonance imaging of the joints as a possible method to improve the evaluation of treatments.

Timeline

Start
2007-02
Primary completion
2011-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rituximab Monoclonal antibody 1000 mg Intravenous

Indications